* Indications: – Treatment of acute and chronic schizophrenic psychoses and other psychotic conditions in which positive symptoms (such as hallucinations, delusion, thought disturbances, hostility, suspiciousness) and / or negative symptoms (such as blunted affect, emotional and social withdrawal, poverty of speech) are perminent. – Alleviates affective symptoms (such as depression, guilt feelings, anxiety) associated with schizophrenia.* Dosage & Administration: Switching form other antipsychotics, where medically appropriate, gradual withdrawal of the previous treatment while Psychodal (risperidone) therapy is recommended. – Adults: All patients whether acute or chronic cases, should start with 2mg/day risperidone. The dosage should be increased to 4mg/day on the second day and 6mg/day on the third day, then the dose can be maintained unchanged. The usual optimum dose is 4 – 8 mg / day however, some patients may benefit from lower doses. – Special population: Eldely, debilitated, patients with severe renal or hepatic impairment, and patients either prediposed to hypotension or for whom hypotension would pose a risk. A starting dose of 0.5mg twice daily is recommended. This dose can be increased to 1-2mg twice daily. – Children: Experience is lacking in children aged less than 15 years.* Store between 15-30 degrees C in a cool dry place and protect from light.* Produced by: Al-Debeiky Pharmaceutical Products, for: DELTA PHARMA S.A.E. – A.R.E.